Ask about this productRelated genes to: TCTA antibody
- Gene:
- TCTA NIH gene
- Name:
- T cell leukemia translocation altered
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 3p21.31
- Locus Type:
- gene with protein product
- Date approved:
- 1995-08-11
- Date modifiied:
- 2017-12-06
Related products to: TCTA antibody
Related articles to: TCTA antibody
- Higher-order multiple gestations (HOM), defined as pregnancies with three or more fetuses, have increased due to assisted reproductive technologies (ART). However, they are associated with significant maternal and fetal risks, including preterm birth and complications from monochorionic placentation. - Source: PubMed
Publication date: 2026/04/17
Valappil SaudabiBalakrishnan Bindu ValiyakkilAl Ghazo Neda MohammadRajesh SharmaBricker Leanne - Triplet pregnancies carry high risks of prematurity and subsequent neurodevelopmental disorders. Fetal reduction from triplets to twins improves short-term obstetric outcomes, but long-term neurodevelopmental outcomes among surviving children remain uncertain. - Source: PubMed
Publication date: 2026/04/16
Larsen Mads LKristensen Steffen ERasmussen Maria KHoei-Hansen Christina EPetersen Olav B - Vapor-deposited glasses of organic semiconductors are frequently used as active layers for organic luminescence devices, such as organic light-emitting diodes. Although it is well known that the aggregation of dopants is a significant factor determining device performance and lifetime, information about the dispersion of the dopants has usually been obtained indirectly using techniques such as photoluminescence spectra. In this work, we use grazing incidence wide-angle x-ray scattering (GIWAXS) to directly probe component segregation in co-deposited glasses of TCTA and Ir(ppy)3, a popular light emitter, across the wide range of compositions and substrate temperatures. As a complementary tool, differential scanning calorimetry and spectroscopic ellipsometry were utilized to further probe segregation and anisotropy of co-deposited glasses. We find that component segregation is observed in the vapor-deposited glasses, at all compositions we studied [10%, 30%, and 50% of Ir(ppy)3 concentration], as identified by an anisotropic scattering peak, resulting from clusters of periodically arranged Ir(ppy)3 molecules. As a result, this paper provides a novel route to probe component segregation in co-deposited glasses by GIWAXS. - Source: PubMed
Lee YejungJu JianzhuCheng ShinianYu JunguangYu LianEdiger M D - Dopant-free poly(3-hexylthiophene) (P3HT) has attracted increasing interest as a stable and solution-processable hole-transporting layer (HTL) for perovskite solar cells (PSCs), yet its relatively weak interfacial contact and limited hole-extraction capability remain major constraints on device efficiency. Here, we demonstrate an effective interfacial engineering strategy using two π-conjugated molecules, triphenylamine (TPA) and 4,4',4″-tricarboxytriphenylamine (TCTA), to simultaneously regulate the perovskite/P3HT interface and suppress interfacial defects. The benzene-ring frameworks of TPA and TCTA enable strong π-π stacking interactions with the thiophene units of P3HT, improving molecular ordering and facilitating more efficient hole transport. Meanwhile, the carboxyl groups in TCTA provide robust coordination with undercoordinated Pb, leading to superior defect passivation and more favorable energy-level alignment at the interface. As a result, TCTA-treated devices exhibit significantly enhanced charge extraction, reduced nonradiative recombination, and improved operational stability. Benefiting from these synergistic effects, the power conversion efficiency of dopant-free P3HT-based PSCs is boosted from 12.66% to 17.17% and 19.68% for TPA- and TCTA-modified devices, accompanied by markedly improved moisture stability and long-term durability. This work provides a promising molecular design principle for constructing high-performance and stable dopant-free P3HT-HTL-based PSCs. - Source: PubMed
Publication date: 2026/03/20
Long YueWang GangXiao LiXu HangLi WeikuiJiang ZezhuanLi ZhenzhenWang ChaotingZhang ZhukangLi Cheng - Triplet pregnancies are associated with high rates of complications, including miscarriage, preterm birth, and selective fetal loss. We present a case of a 42-year-old Caucasian woman with a history of infertility, multiple failed in vitro fertilization (IVF) attempts, and one prior pregnancy loss at 26 weeks of gestation due to placenta previa. She conceived trichorionic triamniotic (TCTA) triplets following intracytoplasmic sperm injection (ICSI) with donor oocytes. At 18 weeks and five days, she developed preterm premature rupture of membranes (PPROM) with umbilical cord prolapse of one fetus, which already had no detectable fetal heart activity. Intrauterine cord ligation (IUCL) was performed, and the demised fetus was retained until expulsion the following day. Conservative management with progesterone support, antibiotics, anticoagulation, tocolysis with atosiban (OXTR/V1A oxytocin and vasopressin V1A receptor antagonist), and antihypertensive therapy allowed prolongation of the pregnancy. Despite challenges including intrauterine growth restriction (IUGR), hypertension, hypothyroidism, and anemia, the remaining two fetuses continued to develop with reassuring Doppler ultrasonography (DUS) findings. At 33 weeks and two days, she underwent urgent cesarean delivery of two viable preterm infants for non-reassuring fetal heart rates (FHRs). This case highlights that with individualized management and intensive monitoring, continuation of pregnancy after selective fetal loss in a triplet gestation is possible, improving neonatal outcomes. - Source: PubMed
Publication date: 2026/01/23
Karam FarahJaalouk NourAzoury Joseph